SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CICCONE, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.768
AS - Asia 2.711
EU - Europa 1.600
SA - Sud America 378
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 52
OC - Oceania 8
Totale 10.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.623
SG - Singapore 1.014
CN - Cina 747
DE - Germania 346
VN - Vietnam 317
IT - Italia 306
BR - Brasile 284
UA - Ucraina 208
GB - Regno Unito 189
HK - Hong Kong 169
TR - Turchia 142
FR - Francia 106
FI - Finlandia 103
BD - Bangladesh 92
CA - Canada 82
SE - Svezia 75
RU - Federazione Russa 71
JP - Giappone 63
IN - India 59
MX - Messico 42
PL - Polonia 40
AR - Argentina 28
CZ - Repubblica Ceca 26
ES - Italia 25
NL - Olanda 25
ID - Indonesia 23
BE - Belgio 21
IQ - Iraq 19
LT - Lituania 18
ZA - Sudafrica 18
EC - Ecuador 17
CO - Colombia 13
VE - Venezuela 13
CL - Cile 12
PK - Pakistan 10
RO - Romania 9
AT - Austria 8
SA - Arabia Saudita 8
EG - Egitto 7
MA - Marocco 7
MY - Malesia 7
AU - Australia 6
IL - Israele 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
KE - Kenya 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
ET - Etiopia 4
IR - Iran 4
JM - Giamaica 4
KR - Corea 4
PY - Paraguay 4
BG - Bulgaria 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
OM - Oman 3
PH - Filippine 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
HU - Ungheria 2
KG - Kirghizistan 2
LY - Libia 2
MT - Malta 2
NI - Nicaragua 2
PT - Portogallo 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
RW - Ruanda 1
SR - Suriname 1
TO - Tonga 1
Totale 10.519
Salva come PNG Salva come JPEG
Città #
Ashburn 686
Singapore 670
Woodbridge 467
Fairfield 391
San Jose 389
Houston 321
Beijing 290
Chandler 259
Santa Clara 232
Jacksonville 224
Ann Arbor 179
Seattle 161
Hong Kong 160
Cambridge 148
Wilmington 137
New York 125
Los Angeles 123
Council Bluffs 116
Ho Chi Minh City 96
Munich 87
Dallas 83
Hanoi 74
Nanjing 71
Izmir 70
Tokyo 57
Princeton 54
Ferrara 51
Milan 51
Shanghai 50
Lauterbourg 41
Boardman 40
San Diego 40
São Paulo 40
Warsaw 38
Addison 37
Turku 32
Buffalo 28
London 27
Helsinki 26
Montreal 26
Shenyang 26
Bremen 25
Phoenix 25
Mexico City 23
Orem 23
Toronto 22
Brussels 21
Denver 21
Brooklyn 20
Nanchang 20
Chicago 19
Frankfurt am Main 19
Haiphong 19
Manchester 19
Stockholm 19
Da Nang 18
Poplar 18
Chennai 17
San Francisco 17
Hebei 15
Hefei 15
Johannesburg 15
Rome 15
Brno 14
Falkenstein 13
Tianjin 13
Amsterdam 12
Changsha 12
Elk Grove Village 12
Jinan 12
Naples 12
Atlanta 11
Bologna 11
Boston 11
Jakarta 11
Mumbai 11
Rio de Janeiro 11
Auburn Hills 10
Augusta 10
Guangzhou 10
Moscow 10
Olomouc 10
Zhengzhou 9
Baghdad 8
Biên Hòa 8
Orange 8
The Dalles 8
Ankara 7
Charlotte 7
Dearborn 7
Guayaquil 7
Hải Dương 7
Jiaxing 7
Madrid 7
Nuremberg 7
Ottawa 7
San Mateo 7
Philadelphia 6
Santiago 6
Can Tho 5
Totale 6.992
Salva come PNG Salva come JPEG
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 308
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 297
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 288
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 277
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 276
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 274
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 273
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 270
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 266
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 264
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 263
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 260
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 253
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 249
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 248
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 245
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 243
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 234
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 232
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 229
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 228
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 222
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 221
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 221
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 219
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 218
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 216
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 214
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 213
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 211
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 203
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 202
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 201
Neoplastic circulating endothelial cells in hematologic malignancies 189
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 185
Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia 183
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 179
Molecular cytogenetic lesions in chronic lymphocytic leukemia 174
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 172
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 161
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 160
Significato dell'analisi citogenetica e citogenetico-molecolare nella diagnosi e nella prognosi delle neoplasie ematologiche. Cytogenetics and molecular cytogenetics in diagnosis and prognosis of haematological malignancies 148
TRISOMY 8 IN PDGFRB-NEGATIVE CELLS IN A PATIENT WITH IMATINIB SENSITIVE CHRONIC MYELOMONOCYTIC LEUKAEMIA AND THE T(5;16)(Q33;P13)/PDGFRB/NDE1 FUSION 145
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 142
Neoplastic circulating endothelial cells in hematologic malignancies 139
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 130
Neoplastic circulating endothelial cells in hematologic malignancies. 115
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 91
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow sample. 80
null 59
null 55
null 45
Totale 10.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 748
Totale 45.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022422 0 0 0 16 29 23 24 18 11 46 56 199
2022/2023562 55 31 24 69 111 73 31 55 60 5 26 22
2023/2024277 28 37 10 7 11 56 12 22 7 6 6 75
2024/20251.276 16 42 91 51 170 149 13 44 201 105 197 197
2025/20263.966 400 166 284 534 619 274 448 225 346 394 148 128
2026/2027733 91 195 336 111 0 0 0 0 0 0 0 0
Totale 10.590